UFF
ADMA icon

USA Financial Formulas’s ADMA Biologics ADMA Stock Holding History

USA Financial Formulas’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,817
Closed -$136K – 288
2024
Q3 		$136K Buy
6,817
+539
+9% +$8.38K 0.02% 172
2024
Q2 		$70.2K Buy
+6,278
New +$52.7K 0.01% 204

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

USA Financial Formulas's ADMA Position: Q4 2024 in Review

USA Financial Formulas sold out of ADMA Biologics (ADMA) in Q4 2024, closing a stake of 6,817 shares — an estimated $136K sold.

USA Financial Formulas first reported a position in ADMA in Q2 2024 and held it in 2 quarters. The position peaked at $136K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

  • USA Financial Formulas reported no remaining ADMA Biologics position as of Q4 2024 after selling out during the quarter.
  • USA Financial Formulas sold 6,817 ADMA Biologics shares in Q4 2024, an estimated $136K.
  • USA Financial Formulas first reported a position in ADMA Biologics in Q2 2024 and held it in 2 quarters.
  • USA Financial Formulas's ADMA Biologics position peaked at $136K in Q3 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on USA Financial Formulas's 13F filing for Q4 2024, filed 14 Jan 2025.